Loading
Latest filing published 29 Apr 2018 for Immunovaccine Inc., €64k.
This profile gathers the share dealings of Alfred Smithers in Immunovaccine Inc. In total, 14 filings cover trades dated from 25 September 2014 to 26 April 2018.
On the open market, the record shows 7 purchases worth €302k and 1 sale worth €203k. Taken together, the purchases exceed the sales by €99k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2018, the count stands at 6 purchases and no sales.
A typical purchase (the median) is worth €46k. No cluster: in 7 purchases, no other insider of the company bought within 30 days.
The record was last updated on 29 April 2018 with an open-market purchase (€64k) in Immunovaccine Inc. The median gap between a trade and its publication by SEDI is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations